Literature DB >> 25937396

An Unusual Complication of the Ventricular Septal Defect Closure by Device: Late Right Aortic Cusp Perforation.

M Sah Topcuoglu1, Atakan Atalay2, Ugur Gocen2, Yasin Guzel2, Yuksel Basturk2, Fadli Demir3.   

Abstract

Aortic regurgitation (AR) is a rare complication of transcatheter closure of perimembranous ventricular septal defects (pmVSD). It results from iatrogenic pinching of the aortic valve by the VSD occluder or perforation by the catheter. It is usually detected during control echocardiography (ECHO). The current study reports the first case of a late AR, which resulted from late right coronary cusp perforation by the VSD occluder. The current manuscript discusses the possible causes of late cusp erosion due to occluder, advantages of early operation in such cases, and an alternative treatment method where the occluder removal is not possible at the operation.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  Aortic regurgitation; Aortic valve; Occluder; Transcatheter closure; Ventricular septal defect

Mesh:

Year:  2015        PMID: 25937396     DOI: 10.1016/j.hlc.2014.11.010

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN: 1443-9506            Impact factor:   2.975


  3 in total

1.  A case of acute myocardial infarction after successful transcatheter closure of ventricular septal defect.

Authors:  Liu Xianglan; Wu Jian; Gu Xia; Chi Di; Zhu Jingyi; Zhang Bo; Yu Bo; Sun Yong
Journal:  Eur Heart J Suppl       Date:  2016-05-24       Impact factor: 1.803

2.  Should we close small ventricular septal defects?

Authors:  Sangeetha Viswanathan; R Krishna Kumar
Journal:  Ann Pediatr Cardiol       Date:  2017 Jan-Apr

3.  Safety and Efficacy of Transcatheter Occlusion of Perimembranous Ventricular Septal Defect with Aortic Valve Prolapse: A Six-Year Follow-Up Study.

Authors:  Wenqian Zhang; Chaojie Wang; Shenrong Liu; Lingmei Zhou; Junjie Li; Jijun Shi; Mingyang Qian; Shushui Wang; Yu-Mei Xie; Zhiwei Zhang
Journal:  J Interv Cardiol       Date:  2021-03-18       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.